José Vázquez-Prado

6PUBLICATIONS
7CO-AUTHORS
Adversarial machine learningPredictive and prognostic markersCell development, proliferation and deathMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 02, 2026
α 1A-Adrenergic receptor (ADRA1A) signaling signatures as prognostic biomarkers in liver hepatocellular carcinoma: a bioinformatic analysis.

|Jun 23, 2026
Pan-cancer signaling landscape linked to endothelial and immune Sphingosine-1-phosphate receptor 1 (S1PR1) expression.

|Dec 23, 2023
Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch.

Ismael Bracho-Valdés, Rodolfo Daniel Cervantes-Villagrana, Yarely Mabell Beltrán-Navarro

|Nov 25, 2023
Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types.

Dante Gustavo Juan-Guadarrama, Yarely Mabell Beltrán-Navarro, Guadalupe Reyes-Cruz

|Nov 14, 2023
Oncogenic Gαq activates RhoJ through PDZ-RhoGEF.

Rodolfo Daniel Cervantes-Villagrana, Víctor Manuel Color-Aparicio, Alejandro Castillo-Kauil

|Nov 18, 2018
Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gαq and Gα13 proteins.

Rodolfo Daniel Cervantes-Villagrana, Sendi Rafael Adame-García, Irving García-Jiménez

Pageof 1

Frequent Collaborators

3 joint publications

Rodolfo Daniel Cervantes-Villagrana

3 joint publications

Guadalupe Reyes-Cruz

2 joint publications

Yarely Mabell Beltrán-Navarro

1 joint publications

Evi Kostenis